{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:56:26Z","timestamp":1720173386256},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.dld.2009.07.022","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T09:41:28Z","timestamp":1263980488000},"page":"428-431","source":"Crossref","is-referenced-by-count":24,"title":["Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease"],"prefix":"10.1016","volume":"42","author":[{"given":"Maria","family":"Siano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartolo","family":"Boggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Sepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasqualina","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Buonpensiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Di Pasqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Raia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2009.07.022_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2009.07.022_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1126\/science.2570460","article-title":"Identification of the cystic fibrosis gene: genetic analysis","volume":"245","author":"Karem","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.dld.2009.07.022_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/347382a0","article-title":"Expression and characterization of the cystic fibrosis transmembrane conductance regulator","volume":"347","author":"Gregory","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.dld.2009.07.022_bib4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ng0396-280","article-title":"Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor","volume":"12","author":"Rozmahel","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.dld.2009.07.022_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/adc.66.6.698","article-title":"Prevalence of liver disease in cystic fibrosis","volume":"6","author":"Scott-Jupp","year":"1991","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.dld.2009.07.022_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2004.10.002","article-title":"Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?","volume":"41","author":"Colombo","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2009.07.022_bib7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","article-title":"Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells","volume":"105","author":"Cohn","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2009.07.022_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/prrv.2001.0170","article-title":"Liver disease in children with cystic fibrosis","volume":"2","author":"Diwakar","year":"2001","journal-title":"Peadiatr Respir Rev"},{"key":"10.1016\/j.dld.2009.07.022_bib9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/jhep.2002.37136","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2009.07.022_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0022-3476(94)70361-2","article-title":"Analysis of risk factors for the development of liver disease associated with cystic fibrosis","volume":"24","author":"Colombo","year":"1994","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2009.07.022_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","article-title":"Effects of liver transplantation on nutritional status of patients with cystic fibrosis","volume":"18","author":"Colombo","year":"2005","journal-title":"Transplant International"},{"key":"10.1016\/j.dld.2009.07.022_bib12","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0016-5085(93)90672-Y","article-title":"Hepatoprotective properties of ursodeoxycholic acid","volume":"104","author":"Douglas","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2009.07.022_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(93)90653-T","article-title":"Molecular aspects of membrane stabilization by ursodeoxycholate","volume":"104","author":"Guldutuna","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2009.07.022_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.31.8.918","article-title":"Effects of ursodeoxicholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis","volume":"31","author":"Cotting","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.dld.2009.07.022_bib15","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxicolic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2009.07.022_bib16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3476(05)81103-5","article-title":"Effects of ursodeoxycolic acid therapy for liver disease associated with cystic fibrosis","volume":"117","author":"Colombo","year":"1990","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2009.07.022_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3476(05)82561-2","article-title":"Effects of ursodeoxycolic acid on liver function in patients with cystic fibrosis and chronic cholestasis","volume":"121","author":"Galabert","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2009.07.022_bib18","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","article-title":"Scintigraphic documentation of an improvement in epatobiliary excretory function after treatment with ursodeoxicolic acid in patients with cystic fibrosis and associated liver disease","volume":"15","author":"Colombo","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2009.07.022_bib19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00004836-200104000-00009","article-title":"Long term prospective study of effect of ursodeoxicolic acid on cystic fibrosis-related liver disease","volume":"32","author":"Nousia Arvanitakis","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2009.07.022_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hep.510230627","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2009.07.022_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: a European Consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.dld.2009.07.022_bib22","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jpedsurg.2006.05.014","article-title":"Clinical outcome of cystic fibrosis presenting with or without meconium ileus: a matched cohort study","volume":"41","author":"Munck","year":"2006","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.dld.2009.07.022_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1183\/09031936.01.00053701","article-title":"The impact of meconium ileus on the clinical course of children with cystic fibrosis","volume":"18","author":"Evans","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.dld.2009.07.022_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ppul.20092","article-title":"Longitudinal pulmonary status of cystic fibrosis children with meconium ileus","volume":"38","author":"Li","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.dld.2009.07.022_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.105.1.53","article-title":"Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening","volume":"105","author":"Lai","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2009.07.022_bib26","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00042737-200310000-00002","article-title":"Meconium Ileus in CF patients is not a risk factor for clinical deterioration and survival: the Israeli multi-center study","volume":"15","author":"Efrati","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2009.07.022_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1651-2227.2007.00250.x","article-title":"Liver disease as risk factor for cystic fibrosis-related diabetes development","volume":"96","author":"Minicucci","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.dld.2009.07.022_bib28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1053\/j.gastro.2007.08.071","article-title":"Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion","volume":"133","author":"Fiorotto","year":"2007","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865809003338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865809003338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T21:59:15Z","timestamp":1544738355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865809003338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1590865809003338"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2009.07.022","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}